145 related articles for article (PubMed ID: 26840084)
21. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.
Niho N; Takahashi M; Kitamura T; Shoji Y; Itoh M; Noda T; Sugimura T; Wakabayashi K
Cancer Res; 2003 Sep; 63(18):6090-5. PubMed ID: 14522940
[TBL] [Abstract][Full Text] [Related]
22. Theracurmin inhibits intestinal polyp development in Apc-mutant mice by inhibiting inflammation-related factors.
Adachi S; Hamoya T; Fujii G; Narita T; Komiya M; Miyamoto S; Kurokawa Y; Takahashi M; Takayama T; Ishikawa H; Tashiro K; Mutoh M
Cancer Sci; 2020 Apr; 111(4):1367-1374. PubMed ID: 31991021
[TBL] [Abstract][Full Text] [Related]
23. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine.
Ono M; Kawahara N; Goto D; Wakabayashi Y; Ushiro S; Yoshida S; Izumi H; Kuwano M; Sato Y
Cancer Res; 1996 Apr; 56(7):1512-6. PubMed ID: 8603395
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
26. A combination of irsogladine maleate and azithromycin exhibits addictive protective effects in LPS-induced human gingival epithelial cells.
Feng X; Liu J
Pharmazie; 2017 Feb; 72(2):91-94. PubMed ID: 29441859
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice.
Mutoh M; Komiya M; Teraoka N; Ueno T; Takahashi M; Kitahashi T; Sugimura T; Wakabayashi K
Int J Cancer; 2009 Dec; 125(11):2505-10. PubMed ID: 19544529
[TBL] [Abstract][Full Text] [Related]
28. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
29. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
30. Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil.
Fujimoto K; Fujii G; Mutoh M; Yasunaga M; Tanaka H; Wada M
Eur J Cancer Prev; 2013 Jan; 22(1):8-10. PubMed ID: 22504657
[TBL] [Abstract][Full Text] [Related]
31. Chemopreventive effect of ERβ-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.
Giroux V; Bernatchez G; Carrier JC
Mol Carcinog; 2011 May; 50(5):359-69. PubMed ID: 21480389
[TBL] [Abstract][Full Text] [Related]
32. Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract.
Akagi M; Amagase K; Murakami T; Takeuchi K
Curr Pharm Des; 2013; 19(1):106-14. PubMed ID: 22950502
[TBL] [Abstract][Full Text] [Related]
33. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
[TBL] [Abstract][Full Text] [Related]
34. Effect of irsogladine maleate on NSAID-induced reduction of gastric mucosal blood flow in anesthetized dogs.
Sato M; Manabe N; Hata J; Ishii M; Kamada T; Kusunoki H; Shiotani A; Haruma K
Digestion; 2009; 79(2):73-8. PubMed ID: 19270456
[TBL] [Abstract][Full Text] [Related]
35. Maslinic acid-enriched diet decreases intestinal tumorigenesis in Apc(Min/+) mice through transcriptomic and metabolomic reprogramming.
Sánchez-Tena S; Reyes-Zurita FJ; Díaz-Moralli S; Vinardell MP; Reed M; García-García F; Dopazo J; Lupiáñez JA; Günther U; Cascante M
PLoS One; 2013; 8(3):e59392. PubMed ID: 23527181
[TBL] [Abstract][Full Text] [Related]
36. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
[TBL] [Abstract][Full Text] [Related]
37. [Activation of nuclear factor-kappaB signaling pathway in rat gastric mucosa during stress ulceration].
Jia YT; Wei D; Chen XL; Xia ZF
Zhonghua Shao Shang Za Zhi; 2006 Oct; 22(5):351-4. PubMed ID: 17283880
[TBL] [Abstract][Full Text] [Related]
38. Sonic hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition.
Kangwan N; Kim YJ; Han YM; Jeong M; Park JM; Go EJ; Hahm KB
Oncotarget; 2016 Feb; 7(7):7667-82. PubMed ID: 26716648
[TBL] [Abstract][Full Text] [Related]
39. Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc(Min/+) mouse model of intestinal cancer, association with enhanced polyp development.
Mandir N; Englyst H; Goodlad RA
Br J Nutr; 2008 Oct; 100(4):711-21. PubMed ID: 18279550
[TBL] [Abstract][Full Text] [Related]
40. Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study.
Hayashi N; George J; Shiroeda H; Saito T; Toshikuni N; Tsuchishima M; Arisawa T; Tsutsumi M
J Gastroenterol Hepatol; 2013 Jun; 28(6):1015-8. PubMed ID: 23425065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
